The number of publicly-listed US companies continues to decline each year. From a peak of over 7,600 in 1997 the number has shrunk to about 3,600 at the end of 2017. That is a reduction of over 50%. Click to enlarge Source: Where Have All the Public Companies Gone?, April 8, 2018, Bloomberg Despite the fall …
Continue reading ‘On the Total Number of Mutual Funds in the US Market’ »
The biotech sector is soaring this year with the benchmark NYSE Arca Biotechnology Index up by over 27% YTD as of the end of September. Investors’ attraction towards biotech stocks shows no signs of showing as evidenced by many successful IPOs being launched on a weekly basis and also trading volumes. In addition, one of the top viewed pages …
Continue reading ‘Biotech Stocks Are Not For The Faint-Hearted’ »
Contract Research Organizations (CROs) play an important role in medical innovation as more pharmaceutical, biopharmaceutical and medical device companies outsource many of their R&D activities. The top 10 global CROs are listed in the chart below. Here is a brief overview of the CRO industry: In 2017, the global CRO services market is estimated to …
Continue reading ‘The 10 Best Global Contract Research Organizations (CROs) in 2018’ »
The Top 20 Best Selling Drugs in 2018 are shown in the chart below with their sales figures in 2017: Click to enlarge Source: IGEA Hub via microbeminded All of the top selling drugs above are owned by major pharmaceutical firms. For example, the popular brand drug Humira is used to treat rheumatoid arthritis and other related diseases …
Continue reading ‘The Top 20 Best Selling Drugs in 2018: Chart’ »
Equity markets have always overcome crises of all shapes and sizes. The long-term return of stocks as measured in decades is positive. There are always fears and crises for investors to worry about. For example, in the recent past we have the Global Financial Crisis(GFC), the Ebola virus scare, Italian debt crisis, multiple Greek sovereign …
Continue reading ‘Australian Stocks Have Climbed a Wall of Worry Since 1900: Chart’ »